DR. GERALD MARK REAVEN, M.D.
Osteopathic Medicine in Palo Alto, CA
License number
California A19405
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
300 Pasteur Dr Falk Cardiovascular Research Ctr, Palo Alto, CA 94305
Phone
(650) 724-3416
(650) 725-1599 (Fax)
(650) 725-1599 (Fax)
Professional information
Gerald Mark Reaven, Palo Alto CA
Specialties:
General Practice, Internal Medicine, Endocrinology, Diabetes & Metabolism, Cardiovascular Disease, Geriatric Medicine, Geriatric Medicine
Work:
Stanford University
300 Pasteur Dr, Palo Alto, CA 94304 Stanford University
300 Pasteur Dr, Stanford, CA 94305
300 Pasteur Dr, Palo Alto, CA 94304 Stanford University
300 Pasteur Dr, Stanford, CA 94305
Education:
University of Chicago (1953)
Dr. Gerald M Reaven, Stanford CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
Stanford Office
300 Pasteur Dr STE A260, Stanford 94305
(650) 723-5468 (Phone)
300 Pasteur Dr STE A260, Stanford 94305
(650) 723-5468 (Phone)
Languages:
English
Hospitals:
Stanford Office
300 Pasteur Dr STE A260, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
300 Pasteur Dr STE A260, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1953
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1953
Gerald Mark Reaven, Stanford CA
Specialties:
Internist
Address:
300 Pasteur Dr, Stanford, CA 94305
Method And Index For Diagnosing Insulin Resistance
US Patent:
2006007, Apr 6, 2006
Filed:
Sep 30, 2005
Appl. No.:
11/240221
Inventors:
Yuanhong Ma - Los Altos CA, US
Yuanshu Xie - Fremont CA, US
Gerald Reaven - Stanford CA, US
Xingyu Wang - Beijing, CN
Lynn Murry - Fayetteville AR, US
Yuanshu Xie - Fremont CA, US
Gerald Reaven - Stanford CA, US
Xingyu Wang - Beijing, CN
Lynn Murry - Fayetteville AR, US
International Classification:
A61K 49/00, C12Q 1/54
US Classification:
424009100, 435014000
Abstract:
The invention provides a method for the determination on of insulin sensitivity, insulin resistance, and non-insulin dependent Diabetes mellitus based on oral glucose tolerance test data and lipid ratios from reference populations that define an insulin resistance index he invention also provides m for using the IR index to determine disease progression and to evaluate the efficacy of the therapeutic agents. The invention further provides an IR calculator for automating diagnosis, producing and storing patient medical records.
Method And Index For Diagnosing Insulin Resistance
US Patent:
2009019, Jul 30, 2009
Filed:
Jan 28, 2008
Appl. No.:
12/011514
Inventors:
Yuanhong Ma - Los Altos CA, US
Yuanshu Xie - Fremont CA, US
Gerald Reaven - Stanford CA, US
Xingyu Wang - Beijing, CN
Lynn Ellen Murry - Fayetteville AR, US
Yuanshu Xie - Fremont CA, US
Gerald Reaven - Stanford CA, US
Xingyu Wang - Beijing, CN
Lynn Ellen Murry - Fayetteville AR, US
International Classification:
C12Q 1/54, C12Q 1/60
US Classification:
435 11, 435 14
Abstract:
The invention provides methods for the determination of insulin sensitivity, insulin resistance, and non-insulin dependent Diabetes mellitus based on oral glucose tolerance test data and lipid ratios from reference populations that define an insulin resistance index. The invention also provides methods for using the IR index to determine disease progression and to evaluate the efficacy of therapeutic agents. The invention further provides an IR calculator for automating diagnosis, producing and storing patient medical records.